Search filters

List of works by Carlos M Rodriguez-Ortigosa

A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver

scientific article published on 25 July 2014

A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury

scientific article published in April 2003

AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers

scientific article published on 18 August 2011

Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I.

scientific article published in March 2002

Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger

scientific journal article

Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications.

scientific article

Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat.

scientific article

Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma

scientific article published on 04 January 2019

Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats

scientific article published on May 2002

Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice

scientific article published on 5 October 2017

Enhanced actions of insulin-like growth factor-I and interferon-alpha co-administration in experimental cirrhosis.

scientific article published on 9 June 2008

Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion

scientific article published on 01 July 1997

Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.

scientific article published on January 2005

Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis.

scientific article published on March 2017

Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration

scientific article published on 24 January 2017

Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(-/-) mice.

scientific article published on 14 February 2013

Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice.

scientific article published on 12 July 2011

Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis

scientific article published on 5 October 2006

Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice.

scientific article published on 12 September 2017

Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice

scientific article

Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition

scientific article published on 05 August 2020

S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver

scientific article published on 01 August 1997

Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins

scientific article published on 01 April 2019

Taurocholate-stimulated leukotriene C4 biosynthesis and leukotriene C4-stimulated choleresis in isolated rat liver

scientific article published on 01 June 1995

The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.

scientific article published on 12 September 2009

Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.

scientific article

Paulina is supported by:

About Paulina

Help